Identification of Celastramycin as a Novel Therapeutic Agent for Pulmonary Arterial Hypertension-High-throughput Screening of 5,562 Compounds-
2019
Rationale: Pulmonary arterial hypertension (PAH) is characterized by enhanced proliferation of pulmonary artery smooth muscle cells (PASMCs) accompanying increased production of inflammatory factor...
Keywords:
- Correction
- Cite
- Save
- Machine Reading By IdeaReader
41
References
0
Citations
NaN
KQI